| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/31/2007 | CN1905912A Cell growth-inhibiting film, medical instrument and stent for digestive organs |
| 01/31/2007 | CN1905897A Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/31/2007 | CN1905892A Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/31/2007 | CN1904039A Ox embryo in vitro culturing liquid containing tea polyphenol and its culturing method |
| 01/31/2007 | CN1904038A Cow ovum cell in vitro ripening culturing liquid containing tea polyphenol and its culturing method |
| 01/31/2007 | CN1904037A New sarcoma cell line, its establishing method and application |
| 01/31/2007 | CN1903879A Preparation method of high liter, high specificity anti human nerve nest protein monoclone antibody |
| 01/31/2007 | CN1297666C Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/31/2007 | CN1297662C Method for the production of 1,3-propanediol by recombinant organisms compising for vitamin B12 transport |
| 01/31/2007 | CN1297659C Method and device for perfusion and culture of hematopoietic cell |
| 01/31/2007 | CN1297658C Tissue engineering cartilage construction method using bone matrix gelatin |
| 01/31/2007 | CN1297567C Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297324C Tissue engineering autologous complex skin and its preparation method |
| 01/31/2007 | CN1297320C Hair follicle-reconstitution system and animal carrying the same |
| 01/31/2007 | CN1297316C Mutant forms of cholera holotoxin as adjuvant |
| 01/31/2007 | CN1297281C Method for treatment of leukaemia |
| 01/30/2007 | US7169987 Inbred corn line PHAVN |
| 01/30/2007 | US7169986 Inbred corn line PHCWK |
| 01/30/2007 | US7169985 For producing a maize plant, by high yield, excellent early growth, brittle snap tolerance, drought tolerance, as well as root lodging resistance |
| 01/30/2007 | US7169984 Inbred maize line PH4GP |
| 01/30/2007 | US7169981 Corn breeding; inbred corn |
| 01/30/2007 | US7169978 Soybean variety XB38E06 |
| 01/30/2007 | US7169974 Soybean cultivar S050051 |
| 01/30/2007 | US7169973 Soybean variety XB26U05 |
| 01/30/2007 | US7169971 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/30/2007 | US7169970 Use of a recombinagenic Oligonucleobase to make a desired mutation in the chromosomal or episomal sequences of a plant in the gene encoding for 5- enol pyruvylshikimate-3-phosphate synthase (EPSPS) |
| 01/30/2007 | US7169965 Transgenic plants expressing secretory laccase and use thereof |
| 01/30/2007 | US7169915 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds |
| 01/30/2007 | US7169913 Engineered secreted alkaline phosphatase (SEAP) reporter genes and polypeptides |
| 01/30/2007 | US7169912 PRO1017 nucleic acids |
| 01/30/2007 | US7169906 Nucleotide sequences coding polypeptide for use in the treatment of skin and nervous system disorders |
| 01/30/2007 | US7169897 Adipocyte complement related protein ZACRP3X2 |
| 01/30/2007 | US7169895 Human neuronal nicotinic acetylcholine receptor α6 and β3 |
| 01/30/2007 | US7169612 Use of EDG2 receptor in an animal model of heart failure |
| 01/30/2007 | US7169610 Propagating chondrocytes in vitro for treatment or repair of bone disorders |
| 01/30/2007 | US7169609 "Ussing chamber" apparatus; plurality of dual-compartment assay chambers where compartments of each chamber are separated by a cell layer across which ions can flow; use in functional analysis of ion transport proteins in both basic research and drug discovery |
| 01/30/2007 | US7169608 Differentiating stem cells into pancreatic hormone-producing cells for use as tools in regenerating damaged pancreatic tissue and reversing hyperglycemia; tissue engineering |
| 01/30/2007 | US7169607 In vivo induction for enhanced function of isolated hepatocytes |
| 01/30/2007 | US7169606 Lyophilization of human platelets |
| 01/30/2007 | US7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/30/2007 | US7169604 Selective regulation using native PR-39 peptide or one of its shorter-length homologs, for interaction with I kappa B alpha and proteasomes; alteration in the intracellular proteolytic activity of proteasomes; down-regulation of NF kappa B-dependent gene expression |
| 01/30/2007 | US7169589 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169582 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/30/2007 | US7169578 Cell isolation and screening device and method of using same |
| 01/30/2007 | US7169577 Cell isolation and screening device and method of using same |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169569 Screening methods using novel Bt toxin receptors from lepidopteran insects |
| 01/30/2007 | US7169567 Screening for an agonist or an antagonist of PTH receptor activity: |
| 01/30/2007 | US7169566 Metalloproteinases |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169548 Sperm cell processing and preservation systems |
| 01/30/2007 | US7169547 Product from a high concentration of white blood cells with high cell viability; white blood cells are sequestered from the whole blood by preventing coagulation, separating the blood into two components, one rich in white blood cells; centrifugation, sequestering, then freezing |
| 01/30/2007 | US7169434 Drying; extrusion; reducing power needed |
| 01/30/2007 | US7169383 Attaching substances to micro-organisms |
| 01/30/2007 | US7169382 Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2166973C Immortalized human fetal osteoblastic cells |
| 01/30/2007 | CA2132977C Crosslinked biocompatible encapsulation compositions and methods |
| 01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
| 01/30/2007 | CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination |
| 01/25/2007 | WO2007012009A1 Therapeutic reprogramming of germ line stem cells |
| 01/25/2007 | WO2007011941A2 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | WO2007011845A2 Use of a bacillus meti gene to improve methionine production in microorganisms |
| 01/25/2007 | WO2007011797A2 Immunophenotype and immunogenicity of human adipose derived cells |
| 01/25/2007 | WO2007011771A2 Yield increase in plants overexpressing the mtp genes |
| 01/25/2007 | WO2007011693A2 Compositions of placentally-derived stem cells for the treatment of cancer |
| 01/25/2007 | WO2007011670A2 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | WO2007011088A1 Method for culturingand proliferating hematopoietic stem cells and progenitor cells using human endometrial cells |
| 01/25/2007 | WO2007011074A1 Rna expression vector selective to nervous system cell |
| 01/25/2007 | WO2007011041A1 Genetically modified antibody composition |
| 01/25/2007 | WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent |
| 01/25/2007 | WO2007010941A1 Antigen and monoclonal antibody capable of recognizing the antigen |
| 01/25/2007 | WO2007010924A1 Gelatinized product of cell, and preparation system for high density cell or tissue array |
| 01/25/2007 | WO2007010858A1 Pluripotent stem cell cloned from single cell derived from skeletal muscle tissue |
| 01/25/2007 | WO2007010853A1 Method for control of electroporation apparatus |
| 01/25/2007 | WO2007010840A1 MULTIPLE shRNA EXPRESSION VECTOR |
| 01/25/2007 | WO2007010740A1 Novel endoribonuclease |
| 01/25/2007 | WO2007010651A1 Novel proteins and method of using the same |
| 01/25/2007 | WO2007010545A1 Rtbv plant promoter and process thereof |
| 01/25/2007 | WO2007010406A2 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 01/25/2007 | WO2007010398A2 Caveolin-3 and in vitro culture of hepatitis c virus |
| 01/25/2007 | WO2007010287A1 Biological materials and uses thereof |
| 01/25/2007 | WO2007010259A1 T cell memory assay |
| 01/25/2007 | WO2007010028A1 Cell line for producing coronaviruses |
| 01/25/2007 | WO2007009981A1 Medium and process for tissue cultivation |
| 01/25/2007 | WO2007009356A1 A method for detecting and culturing pancreatic cells and their application |
| 01/25/2007 | WO2007009285A1 Cryo-conservation medium for in-vitro cultured cells |
| 01/25/2007 | WO2007009235A1 Method and apparatus for guiding growth of neurons |
| 01/25/2007 | WO2007009166A1 Modulation of granulosa cell apoptosis |
| 01/25/2007 | WO2006116545A3 Spatial control of signal transduction |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006097708A3 Affinity purification of protein |
| 01/25/2007 | WO2006083286A3 Genetically engineered swine influenza virus and uses thereof |
| 01/25/2007 | WO2006071794A3 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/25/2007 | WO2006056304A3 Control of indoleamine 2,3 deoxygenase expression and activity |
| 01/25/2007 | WO2006039484A3 Method for chondrocyte expansion with phenotype retention |
| 01/25/2007 | WO2006039238A3 Irta2 antibodies and methods of use |